AI-Powered Blood Test Diagnoses Pediatric Long COVID
An AI-based blood test has detected unique blood plasma biomarkers in children with Long COVID, achieving a 93% diagnostic accuracy in a collaborative study.
Published on April 13, 2025
A collaborative study has harnessed artificial intelligence to pinpoint a unique molecular signature in the blood plasma of children with Long COVID. The research, conducted by teams including experts from Italian institutions, led to the development of an AI-based blood test that achieved a diagnostic accuracy of 93%, offering a promising tool for early and precise identification of the condition.
Published on January 24, 2025, in several reputable sources, the study revealed that affected children exhibited distinct inflammatory and angiogenic protein profiles compared to healthy controls and those with active infections. This breakthrough not only reinforces the potential of AI in clinical diagnostics but also paves the way for routine blood tests in pediatric settings, ensuring timely treatment for Long COVID in children.